Benev - BHA Exfoliator Salicylic 30% - 2oz / 60ml
SKU: BB-2042
BHA Exfoliator Salicylic 30% – 2oz / 60ml (Professional Use Only)
Lipophillc beta-hydroxy peeling agent that concentrates on the pilosebeceous unit and produces very light/superficial to light/level 1 peels.
Key Benefits:
- pH 2.30
- Concentrates on pilosebaceous unit
- Anti-inflammatory
- Corrects clogged/congested pores
- Eliminates excess cellular buildup
- Decreases fine lines
- Reduces pore size
- Improves acne and rosacea skin
The sale of these items may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If so, do not purchase this item unless you are an authorized purchaser. If the item is subject to FDA regulation, we will verify your status as an authorized purchaser of this item before shipping of the item. Required information to Order: Medical License Number (Required), Medical License Owner Name (Required).
- Brand Name: Benev
- Part Number: PB-2042
Key Ingredients:
- Salicylic Acid
Contraindications: Pregnancy, Accutane, Retin A, history of allergy to peel, medication photosensitization, extensive sun exposure, smoking, history of herpes. Fitzpatrick 4
Clinical Use: For complete directions, refer to BENEV Clinical Protocols. PH: 30%: 2.30
How to Use: Mix the acid by gently tipping the bottle back and forth. After skin has been thoroughly degreased and completely dried, apply the acid with 2×2 gauze in a routine application pattern. Leave on skin for 1-3 minutes depending on tolerance. Neutralize acid on skin with cool water. For complete directions, refer to Benev Clinical Protocols.
Lipophillc beta-hydroxy peeling agent that concentrates on the pilosebeceous unit and produces very light/superficial to light/level 1 peels.
Key Benefits:
- pH 2.30
- Concentrates on pilosebaceous unit
- Anti-inflammatory
- Corrects clogged/congested pores
- Eliminates excess cellular buildup
- Decreases fine lines
- Reduces pore size
- Improves acne and rosacea skin
Product Reviews
There are no reviews yet.